Holders — by stockHoldings — by fund
Sands Capital Alternatives, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 1846444
$613.5M
disclosed book value
24
positions
18.7%
largest position share
Positions, as of 2026-06-30
top 24 of 24 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ALMRALAMAR BIOSCIENCES INC | 4.2M | $114.6M | 18.7% |
| 2 | NU HLDGS LTD | 7.1M | $94.8M | 15.4% |
| 3 | KVYOKLAVIYO INC | 3.9M | $59.3M | 9.7% |
| 4 | BBNXBETA BIONICS INC | 3.7M | $58.1M | 9.5% |
| 5 | SGPSPYGLASS PHARMA INC | 2.5M | $55.7M | 9.1% |
| 6 | IKTINHIBIKASE THERAPEUTICS INC | 13.0M | $26.4M | 4.3% |
| 7 | DASHDOORDASH INC | 127,562 | $23.5M | 3.8% |
| 8 | CPNGCOUPANG INC | 1.3M | $23.1M | 3.8% |
| 9 | DDOGDATADOG INC | 80,851 | $21.1M | 3.4% |
| 10 | BIOABIOAGE LABS INC | 786,353 | $19.3M | 3.1% |
| 11 | TXG10X GENOMICS INC | 481,770 | $18.5M | 3% |
| 12 | IOTSAMSARA INC | 515,658 | $16.7M | 2.7% |
| 13 | ODTXODYSSEY THERAPEUTICS INC | 875,000 | $16.4M | 2.7% |
| 14 | TOSTTOAST INC | 364,879 | $10.2M | 1.7% |
| 15 | ABOSACUMEN PHARMACEUTICALS INC | 3.7M | $9.9M | 1.6% |
| 16 | TTANSERVICETITAN INC | 108,545 | $7.7M | 1.3% |
| 17 | CBRSCEREBRAS SYSTEMS INC | 32,825 | $7.3M | 1.2% |
| 18 | SNOWSNOWFLAKE INC | 24,498 | $6.2M | 1% |
| 19 | MONDAY COM LTD | 81,982 | $5.9M | 1% |
| 20 | TARSTARSUS PHARMACEUTICALS INC | 85,000 | $5.3M | 0.9% |
| 21 | TSHATAYSHA GENE THERAPIES INC | 724,873 | $4.9M | 0.8% |
| 22 | CADLCANDEL THERAPEUTICS INC | 405,837 | $4.2M | 0.7% |
| 23 | ACRVACRIVON THERAPEUTICS INC | 2.3M | $4.1M | 0.7% |
| 24 | FIGFIGMA INC | 22,165 | $400,965 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.